|
Editorial
JAMA Dermatology—The Year in Review, 2024
Kanade Shinkai, MD, PhD
AI in Dermatology
Promises and Pitfalls of 3D Total-Body Photography for Melanoma Early Detection
Laura K. Ferris, MD, PhD; Adewole S. Adamson, MD, MPP
Original Investigation
AI in Dermatology
3D Total-Body Photography in Patients at High Risk for Melanoma: A Randomized Clinical Trial
H. Peter Soyer, MD; Dilki Jayasinghe, PhD; Astrid J. Rodriguez-Acevedo, PhD; et al.
Podcast: 3D Total-Body Photography in Patients at High Risk for Melanoma
AI in Dermatology
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma
Daniel Lindsay, PhD; H. Peter Soyer, MD; Monika Janda, PhD; et al.
Systemic Therapies for Psoriatic Disease and Serious Infections in Older Adults
Aaron M. Drucker, MD, ScM; Rinku Sutradhar, PhD; Vicki Ling, MSc; et al.
Editor's Note: Need for Consideration of Patient-Specific Risk Factors in Step Therapy; Andrea D. Maderal, MD
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea: Two Phase 3 Randomized Clinical Trials
Neal Bhatia, MD; James Del Rosso, DO; Linda Stein Gold, MD; et al.
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma
David M. Wang, MD; Michelangelo Vestita, MD; Fadi G. Murad, MD, MPH; et al.
Risk of Major Adverse Cardiovascular Events Following Nicotinamide Exposure
Lee Wheless, MD, PhD; Ranya Guennoun, BS; Basia Michalski-McNeely, MD; et al.
Risk Prediction Models for Sentinel Node Positivity in Melanoma: A Systematic Review and Meta-Analysis
Bryan Ma, MD; Maharshi Gandhi, MPH; Sonia Czyz, MSc; et al.
Brief Report
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial
Andrea M. Gross, MD; Olivia H. Reid, BS; Lauren A. Baldwin, BS; et al.
Inflammatory Signatures in VEXAS Syndrome, Myelodysplasia Cutis, and Sweet Syndrome
Chloé Grolleau, MD, PhD; Maxime Battistella, MD, PhD; Eve Zakine, MD; et al.
Editor's Note
Need for Consideration of Patient-Specific Risk Factors in Step Therapy
Andrea D. Maderal, MD
Images in Dermatology
Folliculitis Decalvans
Lijuan Zhou, MD, PhD; Jinran Lin, MD, PhD; Wenyu Wu, MD
Earn CME credit
Tripe Palms
Pedro Simões Farinha, MD; Margarida Brito Caldeira, MD; João Oliveira Torres, MD
Earn CME credit
JAMA Dermatology Clinicopathological Challenge
Late-Onset Diffuse Xanthomas in an Adult Man
Reid Weisberg, MD; Sameera Husain, MD; Jason E. Liebowitz, MD
Earn CME credit
Recurring Papules and Nodules on the Vulva
Kaila G. Moore, BS; Jayson R. Miedema, MD; Sarah B. Corley, MD, MS
Earn CME credit
Research Letter
Perceived Barriers to Conducting Holistic Review in Dermatology Resident Selection
Isabella I. Sanchez, MD, PhD; Alexandra Kivnick, MD; Cindi Morrill; et al.
At-Home LED Devices for the Treatment of Acne Vulgaris: A Systematic Review and Meta-Analysis
Sherry Ershadi, BS; John S. Barbieri, MD, MBA
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors
Kylie A. Fletcher, BS; Rachel S. Goodman, MD, MBA; Aleigha Lawless, BS; et al.
Observation
Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid
Hiroshi Koga, MD, PhD; Masahiro Tsutsumi, MD; Kwesi Teye, PhD; et al.
Lichen Sclerosus of the Neovagina and Neovulva
Sorcha O’Sullivan, MB, BCh, BAO; Natalia Castrejón de Anta, MD; Stephen Mounsey, MPharm, MBBS; et al.
Audio
3D Total-Body Photography in Patients at High Risk for Melanoma
Comment & Response
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy
Yan-Han Li, MD; Shu-Han Chuang, MD; Hui-Ju Yang, MD
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply
Nathalie Auger, MD, MSc; Kaiyang Li, BSc; Émilie Brousseau, MSc
Correction
Error in Box
Error in Abstract
Error in the Figure
Peer Reviewers List
JAMA Dermatology Peer Reviewers in 2024
JAMA Dermatology Masthead
JAMA Dermatology
|
